Turner Kendrick B, Dean Scott N, Walper Scott A
U.S. Naval Research Laboratory, Washington, DC, United States.
National Research Council Postdoctoral Fellow, Washington, DC, United States.
Methods Enzymol. 2019;617:187-216. doi: 10.1016/bs.mie.2018.12.012. Epub 2019 Jan 25.
Bacterial membrane vesicles, whether naturally occurring or engineered for enhanced functionality, have significant potential as tools for bioremediation, enzyme catalysis, and the development of therapeutics such as vaccines and adjuvants. In many instances, the vesicles themselves and the naturally occurring proteins are sufficient to lend functionality. Alternatively, additional function can be conveyed to these biological nanoparticles through the directed packaging of peptides and proteins, specifically recombinant enzymes chosen to mediate a specific reaction or facilitate a controlled response. Here we will detail mechanisms for directing the packaging of recombinant proteins and peptides into the nascent membrane vesicles (MVs) of Gram-negative bacteria with a focus on both active and passive packaging using both cellular machinery and engineered molecular systems. Additionally, we detail some of the more common methods for bacterial MVs purification, quantitation, and characterization as these methods are requisite for any subsequent experimentation or processing of MV reagents.
细菌膜泡,无论是天然存在的还是经过工程改造以增强功能的,都具有作为生物修复、酶催化以及开发疫苗和佐剂等治疗剂工具的巨大潜力。在许多情况下,膜泡本身和天然存在的蛋白质就足以赋予功能。或者,可以通过定向包装肽和蛋白质,特别是选择用于介导特定反应或促进可控反应的重组酶,将额外的功能赋予这些生物纳米颗粒。在这里,我们将详细介绍将重组蛋白和肽定向包装到革兰氏阴性菌新生膜泡(MVs)中的机制,重点是利用细胞机制和工程分子系统进行主动和被动包装。此外,我们详细介绍了一些更常见的细菌MVs纯化、定量和表征方法,因为这些方法是MV试剂后续任何实验或处理所必需的。